HOW TO INVEST IN ALZHEIMER’S STOCKS – LECANUMAB DATA $BIIB $LLY $RHHBY $NBIX $ACAD $IONS $ITCI
Today - we all have something to celebrate - Biogen and Eisai were developing lecanumab for treatment of Alzheimer disease (after aducanumab flopped) and despite much skepticism, lecanumab Phase 3…